These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6869318)

  • 21. Phase II study of mitoxantrone in patients with non-small cell lung cancer.
    Suga J; Saijo N; Shinkai T; Eguchi K; Sasaki Y; Sakurai M; Sano T; Tamura T; Hoshi A
    Jpn J Clin Oncol; 1986 Jun; 16(2):147-51. PubMed ID: 3735704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I-II trial of mitoxantrone in acute leukemia: an interim report.
    Arlin ZA; Dukart G; Schoch I; Reisman A; Moore J; Silver RA; Cassileth P; Bertino J; Gams R
    Invest New Drugs; 1985; 3(2):213-7. PubMed ID: 3860491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II studies of mitoxantrone (dihydroxyanthracenedione) in the treatment of advanced colorectal carcinoma.
    DeSimone PA; Gams R; Bartolucci A
    Am J Clin Oncol; 1984 Oct; 7(5):517-22. PubMed ID: 6507372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Southwest Oncology Group study of Mitoxantrone for treatment of patients with advanced squamous cell carcinoma of the head and neck.
    Mattox DE; Clark GM; Balcerzak SP; O'Bryan RM; Oishi N; Stuckey WJ
    Invest New Drugs; 1984; 2(4):405-7. PubMed ID: 6511243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of vincristine, mitomycin-C and mitoxantrone in advanced breast cancer: a preliminary report of response and toxicity.
    Perren TJ; Blackledge G; Mould JJ; Chetiyawardana AD; Morrison M; Hancock A
    Invest New Drugs; 1985; 3(2):173-7. PubMed ID: 3926713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Phase II study of mitoxantrone].
    Tada A; Ogawa M; Usui N; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Adachi K; Nakada H; Okada Y
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1649-54. PubMed ID: 6476838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitoxantrone in malignant melanoma.
    Presant CA; Gams R; Bartolucci A
    Cancer Treat Rep; 1984 Jun; 68(6):903-5. PubMed ID: 6733704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitozantrone as single agent therapy in hepatocellular carcinoma. A phase II study.
    Dunk AA; Scott SC; Johnson PJ; Melia W; Lok AS; Murray-Lyon I; Williams R; Thomas HC
    J Hepatol; 1985; 1(4):395-404. PubMed ID: 2997322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitoxantrone (NSC-301739) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group.
    Muss HB; Asbury R; Bundy B; Ehrlich CE; Graham J
    Am J Clin Oncol; 1984 Dec; 7(6):737-9. PubMed ID: 6528868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Phase II study of mitoxantrone in advanced breast cancer].
    Ogawa M; Kubo K; Tominaga T; Nomura Y; Ota K; Yoshida M; Taguchi T; Hoshino A
    Gan To Kagaku Ryoho; 1986 May; 13(5):1980-4. PubMed ID: 3707156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I clinical trial f mitoxantrone: a new anthracenedione anticancer drug.
    Alberts DS; Griffith KS; Goodman GE; Herman TS; Murray E
    Cancer Chemother Pharmacol; 1980; 5(1):11-5. PubMed ID: 7460190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
    Meyer P; Ho AD; Ehninger G; Mjaaland I; Heidemann E; Seither E
    Invest New Drugs; 1985; 3(2):203-6. PubMed ID: 3860490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II trial of piroxantrone in metastatic gastric adenocarcinoma.
    Pazdur R; Bready B; Scalzo AJ; Brandof JE; Close DR; Kolbye S; Winn RJ
    Invest New Drugs; 1994; 12(3):263-5. PubMed ID: 7896547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitoxantrone in epithelial carcinoma of the ovary. A Southwest Oncology Group study.
    Hilgers RD; Rivkin SE; Von Hoff DD; Alberts DS
    Am J Clin Oncol; 1984 Oct; 7(5):499-501. PubMed ID: 6507370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I trial of dihydroxyanthracenedione.
    Van Echo DA; Whitacre MY; Aisner J; Wiernik PH
    Cancer Treat Rep; 1981; 65(9-10):831-4. PubMed ID: 7273015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I study and pharmacodynamics of piroxantrone (NSC 349174), a new anthrapyrazole.
    Hantel A; Donehower RC; Rowinsky EK; Vance E; Clarke BV; McGuire WP; Ettinger DS; Noe DA; Grochow LB
    Cancer Res; 1990 Jun; 50(11):3284-8. PubMed ID: 2334921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase II study of mitoxantrone in acute leukemia.
    Masaoka T; Shibata H; Oguma S; Nagai K; Kitani T; Horiuchi A; Yasunaga K; Yonezawa T; Kawagoe H
    Invest New Drugs; 1985; 3(2):197-201. PubMed ID: 3860489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Phase II study on MCNU in patients with advanced or recurrent gastrointestinal cancer].
    Niimoto M; Yoshinaka K; Hattori T; Kobayashi S; Hosoma S; Ogawa Y; Iwamori S; Nagata N; Yamagata S; Nishimawari K
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1813-9. PubMed ID: 4037810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas.
    Moertel CG; Rubin J; O'Connell MJ; Schutt AJ; Wieand HS
    J Clin Oncol; 1986 Jul; 4(7):1053-7. PubMed ID: 3014083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I clinical trial with ametantrone (NSC-287513).
    Piccart M; Rozencweig M; Abele R; Cumps E; Dodion P; Dupont D; Kisner D; Kenis Y
    Eur J Cancer Clin Oncol; 1981 Jul; 17(7):775-9. PubMed ID: 7199472
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.